Spermidine Extract Mitochondrial Complex I Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for mitochondrial energy disorders and diseases, such as mitochondrial myopathy and encephalopathy, lack effective solutions for enhancing mitochondrial respiratory activity and reducing reactive oxygen species (ROS) production, which are critical for improving energy production and endurance.
Innovation Solution
Spermidine or a spermidine comprising extract is administered to activate mitochondrial Complex I, thereby increasing respiratory activity, enhancing energy production, and reducing ROS accumulation, which can be formulated for oral or topical use in various forms like capsules, tablets, or ointments, and can be combined with antioxidants for enhanced efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Use of energy by moving object
If mitochondrial respiratory activity is increased to enhance energy production, then energy production is improved, but reactive oxygen species (ROS) accumulation increases
Solution Approach 1:
The patent applies this principle by using spermidine to convert the harmful effect of increased ROS production (which normally accompanies enhanced mitochondrial respiration) into a beneficial outcome. Spermidine activates Complex I to increase energy production while simultaneously reducing ROS accumulation through its unique mechanism of action on mitochondrial function, effectively transforming the harmful byproduct into a manageable or reduced state
Solution Approach 2:
The patent changes the operational parameters of mitochondrial Complex I through spermidine administration. By modifying the activity level and efficiency of Complex I, spermidine enables enhanced respiratory activity and energy production while operating at parameters that minimize ROS generation, thus resolving the contradiction between energy production and ROS accumulation
2Reliability
If Complex I activity is enhanced to improve mitochondrial function, then respiratory activity is improved, but treatment complexity increases
Solution Approach 1:
The patent extracts and isolates the specific active component (spermidine or spermidine-containing extract) responsible for Complex I activation from complex natural sources or treatment regimens. By focusing on this single active agent, the treatment simplifies the approach to enhancing mitochondrial function while maintaining effectiveness, avoiding the need for complex combination therapies
Solution Approach 2:
Spermidine acts as a self-regulating agent that naturally activates Complex I and modulates mitochondrial function without requiring external control mechanisms or complex administration protocols. The substance itself provides the necessary activation and protection, simplifying the treatment approach while ensuring reliable mitochondrial function enhancement
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of spermidine significantly increases mitochondrial energy production, enhances endurance, transforms white adipose tissue into brown adipose tissue, and reduces ROS formation, thereby improving muscle function and overall energy metabolism.
Implementation Method 1
Spermidine is capable of increasing respiratory activity, in particular the Complex I activity, in mammalian mitochondria which leads to an increased production of energy in the cell
Implementation Method 2
Since Complex I is one of the main sites at which premature electron leakage to oxygen occurs, the improvement of its efficiency through spermidine can also be applied for enhancement of antioxidant treatments to reduce reactive oxygen species (ROS) stress
Data Source
Figure 1A~1B
AI summary
The present invention relates to spermidine or spermidine comprising extracts for use in the treatment and/or amelioration of mitochondrial energy disorders or diseases.